Sign in to follow
Search Results

0 results for 'Genentech'

You can use to get even better search results
August 30, 2024 | New York Law Journal

Litigation Department of the Year Finalist, Intellectual Property: Groombridge, Wu, Baughman & Stone

"It's impossible not to single out our role in enjoining Idaho's HB 71, a law banning gender-affirming healthcare for transgender youth. That case underlined our commitment to pro bono work and social justice issues that we believe in."
3 minute read
May 24, 2024 | The Legal Intelligencer

In the Wake of 'Amgen v. Sanofi,' the USPTO Clarifies the Patent Enablement Requirement

This article provides a brief overview of the Amgen decision and USPTO guidelines, and provides some practical guidance on how one might be able to capture a genus of antibodies in light of these recent developments.
7 minute read
February 21, 2024 | Law.com

Treatment of Antibody Claims In the U.S. After 'Amgen v. Sanofi'

The future of antibody claiming in the United States is uncertain following the U.S. Supreme Court's ruling in 'Amgen Inc. v. Sanofi,' a highly anticipated decision concerning enablement and whether the traditional way to claim antibodies — claiming antibodies by their function — will survive as a valid claiming strategy.
8 minute read
January 24, 2024 | National Law Journal

Amid 'Brutal Competition' and Demand in Patent Practices, Orrick Grows IP Group

Arnold & Porter, Crowell & Moring, McCarter & English, and Miles & Stockbridge also picked up D.C. partners in their key practices this past week.
3 minute read
January 16, 2024 | Litigation Daily

Seeking In-House Perspectives on Litigation

Last year in-house litigators from five companies shared lessons learned from their professional journeys and insights about hiring decisions. We want to hear from more of them.
7 minute read
Law Journal Press | Digital Book Florida Construction Defect Litigation 2025 Authors: Gary L. Brown View this Book

View more book results for the query "Genentech"

January 12, 2024 | New York Law Journal

Pharmaceutical Legal and Regulatory Trends To Watch in 2024

This article highlights several notable legal and regulatory developments in 2023 and discusses developments that will continue to shape the pharmaceutical industry in 2024.
8 minute read
November 20, 2023 | New Jersey Law Journal

Genentech, Biogen and Hoffmann-La Roche File Lawsuit Over Planned Release of 'Copycat' of Pioneering Cancer Drug

This complaint was first surfaced by Law.com Radar.
3 minute read
October 04, 2023 | Law.com

Feds' False Claims Act Lawsuit Against Regeneron Gets Partial Go-Ahead for Trial

"The government, like any litigant, is entitled to attempt to prove its case through circumstantial evidence and reasonable inferences," the U.S. District Court for the District of Massachusetts ruled.
6 minute read
September 22, 2023 | Litigation Daily

Litigator of the Week Runners-Up and Shout Outs

Bernstein Litowitz and Kessler Topaz were co-lead counsel in a $450 million securities settlement finalized last week with The Kraft Heinz Company and 3G Capital partners in a case stemming from major write-downs on the Kraft and Oscar Mayer brands post-merger.
6 minute read
April 17, 2023 | Corporate Counsel

Genentech's Mary-Alice Barrett on Building a 'Virtual Firm' to Tackle Litigation That Crosses Jurisdictions

"In-house counsel must be quite involved to establish this culture of collaboration and trust [between lawyers at different firms]," Barrett said. "I think it's a lot more work, but you get better results."
8 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • 2024 Trends Report Mid-Year Special Edition: Update on Outside Counsel Billing Rates

    Brought to you by LexisNexis® CounselLink®

    Download Now

  • AI in Private Equity: A Guide for Gaining an Early Advantage

    Brought to you by Ontra

    Download Now

  • Why Are So Many Law Firms Suddenly Embracing Digital Transformation?

    Brought to you by AllRize

    Download Now

  • 2025 State Legislative Sessions

    Brought to you by LexisNexis®

    Download Now